WELCOME TO GENOME  MEDICAL

We are here to bring genomics
into everyday care

WELCOME TO GENOME  MEDICAL

We are here to bring genomics into everyday care

MEET OUR FOUNDERS

MEET OUR FOUNDERS

Lisa Alderson

Co-Founder

Lisa has 20 years of experience building early-stage companies with a focus on technology, consumer and life sciences businesses. Lisa co-founded Genome Medical and served as its CEO from 2016 to August 2022. Prior to Genome Medical, Lisa served as the chief commercial officer and chief strategy officer of Invitae (NYSE: NVTA), a rapidly growing genetic information company. She was part of the start-up team at Genome Health Inc. (Nasdaq: GHDX), president of Cinema Circle, Inc., and the former manager of strategic planning at The Walt Disney Co.

Randy Scott, PhD

Co-Founder and
Chairman

Randy is a co-founder and chairman at Genome Medical. He was formerly the chairman of Invitae, a company he co-founded and where he previously served as CEO. He also founded Genomic Health and served as Genomic Health’s chief executive officer from 2000 until 2009 and executive chairman until 2012. Under Randy’s leadership, Genomic Health developed and launched two revolutionary cancer diagnostic tests. At Incyte, Randy served in various roles from 1991 through 2000, including chairman of the board, president and chief scientific officer.

Robert Green, MD, MPH

Co-Founder and
Scientific Advisory Board Chair

Dr. Green is co-founder and chairman of Genome Medical’s Scientific Advisory Board. He is a medical geneticist and physician-scientist who directs the G2P Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School. Dr. Green is principal investigator of the MedSeq Project, the first NIH-funded randomized trial to explore the use of whole genome sequencing in the clinical practice of medicine.

Genome Medical is a mission-driven organization bringing genomic medicine to everyday care. We are delivering the future of health care today through our nationwide network of clinical genetic experts and our efficient genomic care delivery platform. Our team is dedicated to improving patient health and reducing the cost of health care delivery.

Lisa AldersonCo-Founder

Learn more about our story and vision for Genome Medical

Our Story

Genome Medical is a mission-driven organization bringing genomic medicine to everyday care. We are delivering the future of health care today through our nationwide network of clinical genetic experts and our efficient genomic care delivery platform. Our team is dedicated to improving patient health and reducing the cost of health care delivery.

Lisa AldersonCo-Founder

Learn more about our story and vision for Genome Medical

Our Story

MEET OUR

LEADERSHIP TEAM

Learn More

MEET OUR

LEADERSHIP TEAM

Learn More

Jill Davies, MS, CCGC

CEO

As a pioneer and leader in the genetics field for nearly 20 years, Jill Davies has dedicated her career to helping patients take action to improve their lives. This passion led her to create GeneMatters in 2016 to increase access to genetic counseling, so more patients can get the timely help they need. When GeneMatters and Genome Medical joined forces in 2021, Jill took the helm as Genome Medical’s Chief Customer Officer before her appointment as CEO in 2022.

Prior to founding GeneMatters in 2016, Jill was Director of Genetics at the Medcan Clinic in Toronto where she was responsible for developing and delivering leading-edge clinical genomics services.

Jill has broad expertise across clinical services, telehealth and the application of genetic counseling in oncology, prenatal, reproductive, cardiology and neurology. She has a special interest in the role of technology to enable access to genomic information.

Jill was named a 2018 recipient of the Top 20 Courageous Women in Minnesota Health Care award, presented by the Women’s Health Leadership Trust. She received this prestigious recognition because of her vision in founding GeneMatters to serve patients who need genetic counseling through telehealth.

Sean Handel

Chief Product Officer

Sean has extensive experience in product leadership and a deep background in digital health, SaaS, clinical decision support tools and medical devices. Before joining Genome Medical, he was CPO at OneOme and held product leadership roles at Proteus Digital Health, Swrve, Epocrates and athenahealth. Sean brings a proven track record building and leading teams to achieve initial product/market fit and scalable streams.

Mark Sylvester, JD

Chief Financial Officer

Mark is the Chief Financial Officer for Genome Medical. Prior to this role, Mark was the COO & CFO for GeneMatters. He has also been the President & CFO of Invenshure, a med-tech incubator located in Minneapolis, MN. During his tenure, he was part of the co-founding team for five medical and biotech companies (including GeneMatters), operated as their early stage CFO, and was instrumental in their go-to-market strategy. Prior to Invenshure, Mark was the CFO at The Emily Program, where he oversaw accounting, finance, payroll and financial analytics. During his tenure, Mark sat on the board of directors, was a member of the senior leadership team, structured a debt and equity recapitalization (via private equity), and was instrumental in business development during a period of rapid growth. He received his law degree from the University of St. Thomas School of Law.

Kristin Ashcraft

Chief Operating Officer

Kristin is the Chief Operating Officer at Genome Medical, where she has overseen Business Operations, Program Management, Legal, People Operations, Customer Success, Product and Finance. Kristin has spent over half her career in the healthcare industry at companies ranging in size and maturity from start-up to the Fortune 500. Prior to Genome Medical, Kristin led Business Operations & Alliance Management at digital health start-up, MyHealthTeams. She also led Commercial Operations at Counsyl Inc. and was there through its acquisition by Myriad Genetics. While at DaVita Inc., Kristin was on the leadership team and played numerous roles as one of the first five business people on an internal start-up, Falcon EHR. Kristin holds an MBA from the UCLA Anderson School of Management and a BA in Biology and Environmental Science and Policy from Duke University.

Kiley Johhson, MS, LCGC

Chief Clinical Officer

Kiley is the Chief Clinical Officer for Genome Medical. Prior to this role, she served as Senior Vice President and Vice President of Clinical Operations for GeneMatters. She has also worked as a genetic counselor at Mayo Clinic where she had a broad range of clinical experience and was integral to the development of the Individualized Medicine Clinic, focused on utilizing new clinical technologies for patient care. Her clinical experiences furthered in the world of telemedicine as a Senior Genetic Counselor with InformedDNA.

MEET OUR

CLINICAL LEADERSHIP TEAM

Learn More

MEET OUR

CLINICAL LEADERSHIP TEAM

Learn More
Steven Bleyl headshot

Steven Bleyl, MD, PhD

Chief Medical Officer

Steve is Genome Medical’s chief medical officer. He is a board-certified medical geneticist and associate professor in medical genetics and pediatrics at the University of Utah. Previously, Steve directed the Clinical Genetics Institute for Intermountain Healthcare in Salt Lake City.

Alan Rope headshot

Alan Rope, MD

Genetics Physicians Lead

Alan is Genome Medical’s genetics physicians lead. He previously served as a staff physician and medical geneticist at Kaiser Permanente Northwest and as an associate clinical professor of pediatrics at the University of Utah School of Medicine.

Scott Weissman headshot

Scott Weissman, MS, CGC

Director, Cancer Genetic Services

Scott serves as Genome Medical’s cancer service lead. He is a board-certified genetic counselor with 15+ years experience in adult-onset genetic disorders and a focus on cancer genetics. He has worked at several hospitals as well as genetic testing labs.

Betsy Swope headshot

Betsy Swope, MS, CGC

Director, Reproductive Genetic Services

Betsy is Genome Medical’s reproductive service lead. She is a board-certified genetic counselor with more than 17 years of experience. She has worked at the University of Michigan, the University of North Carolina and Progenity, Inc.

Lindsay Meyers headshot

Lindsay Meyers, MS, CGC

Director, Clinical Operations

Lindsay is Genome Medical’s cardiovascular service lead. She is a board-certified genetic counselor specializing in cardiac and pediatric genetics. She has over 9 years of experience and helped establish the first genetics service in pediatric cardiology at Primary Children’s Hospital.

Cary Armstrong, MS, LCGC

Director, Genetic Counseling Services, GeneMatters

Cary is a board-certified and licensed genetic counselor. She has more than 19 years of experience in cancer predisposition syndromes. She has developed expansion sites for telegenetic consultations, a cancer genetic risk assessment program and co-facilitated a support group for individuals identified to carry BRCA mutations.

Gillian Bell, PHARMD

Pharmacogenomics Service Lead

Gillian Bell is the Pharmacogenomics Service Lead at Genome Medical and Assistant Professor of Clinical Education in the Division of Practice Advancement and Clinical Education at UNC Eshelman School of Pharmacy. She completed her Pharm.D. at the University of Tennessee College of Pharmacy and 2 years of postgraduate training in pharmacy practice and clinical pharmacogenomics at the Memphis VAMC and St. Jude Children’s Research Hospital, respectively. Prior to joining Genome Medical, she was most recently the Director of Genetics and Personalized Medicine at Mission Health. In addition to her current role, she serves as a member of several national and international working groups focused on implementing pharmacogenomics in clinical care.

MEET OUR

MEDICAL AND SCIENTIFIC AFFAIRS TEAM

MEET OUR

MEDICAL AND SCIENTIFIC AFFAIRS TEAM

Hunt Willard headshot

Hunt Willard, PhD

Chief Scientific Officer

Hunt has deep experience in genetics and genomics leadership in academia, health care and industry, building teams that span research, education and clinical care. Prior to joining Genome Medical, he was most recently director and principal of National Precision Health at Geisinger Health in Maryland and Pennsylvania, with a focus on design and implementation of large-scale clinical and research programs in genomics and population screening. He is the author or co-author of more than 350 scientific publications, co-editor of the Genomic and Precision Medicine book series and a longtime co-author of the textbook Genetics in Medicine. A former president of the American Society of Human Genetics, he is an elected member of the National Academy of Medicine and the National Academy of Sciences.

Erica Ramos headshot

Erica Ramos, MS, CGC

Vice President, Medical and Scientific Affairs

Erica is the vice president of population genomics at Genome Medical. She is responsible for developing the strategy, value proposition and overall approach to population-scale health initiatives utilizing genetics and genomics and is passionate about establishing genomics as a resource for life-long care and integrating broad-based screening approaches with indication-based diagnostic services. In her previous role as director of clinical and product development at Geisinger National Precision Health, she and her team developed and integrated scalable, efficient and innovative clinical programs and products to accelerate the responsible adoption and integration of genomics into preventive care and population health. Prior to joining Geisinger, Erica was an associate director of market development for Precision Health and Screening at Illumina and practiced as a clinical genetic counselor for 11 years. Erica is a nationally recognized leader in the genetic counseling community, serving as the 2018 president of the National Society of Genetic Counselors, the leading professional organization for genetic counselors, more than 4,000 members strong, and serving on the All of Us Research Program Advisory Panel. She is also an adjunct professor in the Genetic Counseling Department at Augustana University and shares her enthusiasm for genomics, genetic counseling and Wisconsin sports on Twitter at @ERamosSD.

Molly McGinniss, MS, CGC

Senior Director of Client and Partner Relations

Molly is a board-certified genetic counselor with extensive clinical and commercial expertise. She joined Genome Medical from Illumina, where she held market development roles focused on expansion of sequencing applications into emerging clinical markets through evidence generation and strategic partnerships. Molly began her career as a clinical genetic counselor providing prenatal, pediatric and adult genetic counseling services and has served on the Board of Directors for the Accreditation Council for Genetic Counseling (ACGC) since 2018 and has held additional leadership roles for the National Society of Genetic Counselors (NSGC). She received her Bachelor’s degree from Loyola Marymount University and her Masters in Genetic Counseling from the Boston University School of Medicine.

Colleen Caleshu, MS, CGC

Senior Director of Clinical Research

Colleen is a pioneer in embedding genetic counseling services within cardiology. Prior to joining GeneMatters she established cardiovascular genetic counseling services for UCSF and also the Stanford Center for Inherited Cardiovascular Disease, where she built the largest cardiovascular genetic counseling team in the world. She has advanced the field of cardiovascular genetics by serving as a member of the ClinGen Cardiovascular Domain Working Group, as a contributor to the American Heart Association working committee on policy recommendations for genetics in cardiology and as chair of the National Society of Genetic Counselors Cardiovascular Genetics Special Interest Group and vice-chair of the NSGC Education Committee.

Beth Denne headshot

Beth Denne, MS, CGC

Director of Education and Engagement

Beth is a board-certified and licensed genetic counselor, practicing since 2000. A leader in the genetic counseling community, Beth has served as president of the American Board of Genetic Counseling and on several committees for the National Society of Genetic Counselors. Prior to joining Genome Medical, Beth was the genetic counseling and education program leader for Geisinger National Precision Health. She previously served as director of genetic counseling services for Counsyl, Inc. During her seven years at Counsyl, she helped to develop and build the genetic counseling service, which incorporated new technologies and alternative service delivery models for telegenetic counseling into standard practice. Beth spent the first 12 years of her career at Johns Hopkins University Hospital as a Gyn/Ob faculty member in the Department of Maternal-Fetal Medicine.

Jenna Petersen, MS, CGC

Lead Content Design, Education and Engagement

Jenna is a board-certified genetic counselor experienced in developing innovative and engaging content for large genomics projects. She is passionate about increasing access to genetic counseling and testing through scalable approaches to education and service delivery. Jenna joined Genome Medical from AncestryDNA, where she provided clinical expertise for the development of consumer-initiated genetic health products.

MEET OUR

BOARD OF DIRECTORS

MEET OUR

BOARD OF DIRECTORS

Randy Scott, PhD

Co-Founder and Chairman

Stephen Bloch, MD

General Partner

Canaan

Eli Casdin, MBA

Founder and Chief Investment Officer

Casdin Capital

Jill Davies, MS, CGC

CEO

Russell Glass

CEO

Headspace Health

Robert Green, MD, MPH

Co-Founder and Scientific Advisory Board Chairman

Brigham and Women’s Hospital/
Harvard Medical School

Shaun Rodriguez, PhD

Director of Life Science Research

Casdin Capital

Jessica Zeaske, PhD, MPH, MBA

Partner

Echo Health Ventures

Keith Figlioli, MBA
(Board Observer)

Investment Partner

LRVHealth

Tim Howe, MBA
(Board Observer)

Managing Partner

HealthInvest Equity Partners

Nick Naclerio, PhD
(Board Observer)

Founding Partner

Illumina Ventures

Anthony Philippakis, MD, PhD
(Board Observer)

Venture Partner

GV

Amy Belt Raimundo, MBA
(Board Observer)

Managing Director

Kaiser Permanente Ventures

Chen Zhou, MBA
(Board Observer)

Investment Director/Principal

Samsung Catalyst Fund

Randy Scott, PhD

Co-Founder and Chairman

Stephen Bloch, MD

General Partner

Canaan

Eli Casdin, MBA

Founder and Chief Investment Officer

Casdin Capital

Jill Davies, MS, CGC

CEO

Russell Glass

CEO

Headspace Health

Robert Green, MD, MPH

Co-Founder and Scientific Advisory Board Chairman

Brigham and Women’s Hospital/
Harvard Medical School

Shaun Rodriguez, PhD

Director of Life Science Research

Casdin Capital

Jessica Zeaske, PhD, MPH, MBA

Partner

Echo Health Ventures

Keith Figlioli, MBA
(Board Observer)

Investment Partner

LRVHealth

Tim Howe, MBA
(Board Observer)

Managing Partner

HealthInvest Equity Partners

Nick Naclerio, PhD
(Board Observer)

Founding Partner

Illumina Ventures

Anthony Philippakis, MD, PhD
(Board Observer)

Venture Partner

GV

Amy Belt Raimundo, MBA
(Board Observer)

Managing Director

Kaiser Permanente Ventures

Chen Zhou, MBA
(Board Observer)

Investment Director/Principal

Samsung Catalyst Fund

INVESTORS

INVESTORS

Casdin Capital logo
Perceptive Advisors logo
Canaan logo
Echo Health Ventures logo
LRV Health logo
Samsung Catalyst Fund Logo
Revelation Partners logo
Avestria Logo
Dreamers VC Logo
Flywheel Ventures logo
Blue Ivy Ventures

The breadth and scale of what Genome Medical provides makes it the clear leader in digital health for genomics. We have been an early and active investor in the development of genetic testing capabilities broadly, and Genome Medical is ideally positioned to rapidly accelerate the availability of genomic medicine for patients and providers.

Eli CasdinFounder and Chief Investment Officer, Casdin Capital

MEET OUR

SCIENTIFIC ADVISORY BOARD

Robert Green headshot

Robert Green, MD, MPH

Genome Medical Scientific Advisory Board Chairman

Robert is a professor of medicine at Harvard Medical School and directs the Genomes2People Research Program in translational genomics at Brigham and Women’s Hospital and Broad Institute. He conducts empirical research on the medical, behavioral and economic outcomes around the implementation of genomic medicine. Dr. Green is directing some of the first trials to explore sequencing in adults (the MedSeq Project) newborn infants (the BabySeq Project) and active-duty military personnel (the MilSeq Project).

Heather Hampel headshot

Heather Hampel, MS, LCGC

Heather is an associate director of the Division of Human Genetics, associate director of biospecimen research at The Ohio State University Comprehensive Cancer Center and former president of the American Board of Genetic Counseling. Ms. Hampel is an internationally recognized cancer genetic counselor whose research has led to changes in standard-of-care genetic screening practices for colon cancer.

Bruce R. Korf headshot

Bruce R. Korf, MD, PHD

Dr. Korf is Associate Dean for Genomic Medicine and Chief Genomics Officer at University of Alabama at Birmingham, and co-directs the UAB-HudsonAlpha Center for Genomic Medicine. He is current president of the American College of Medical Genetics and Genomics Foundation for Genetic and Genomic Medicine and has held leadership roles in most of the major genetics professional societies. In addition, Dr. Korf is at the forefront of developing novel approaches for integrating genetics and genomics into medical practice.

Robert L. Nussbaum headshot

Robert L. Nussbaum, MD

Robert is chief medical officer of Invitae. He is the former chief of the University of California, San Francisco’s Division of Genomic Medicine, and medical director of the Cancer Risk Program and the UCSF Program in Cardiovascular Genetics. He is also the former chief of the Genetic Diseases Research and Inherited Disease Research Branches of the National Human Genome Research Institute and former president of the American Society of Human Genetics.

Heidi L. Rehm headshot

Heidi L. Rehm, PhD, FACMG

Heidi is director of the Partners Healthcare Laboratory for Molecular Medicine, medical director of the Broad Institute’s Clinical Research Sequencing Platform and associate professor of pathology at Brigham and Women’s Hospital and Harvard Medical School. Through her leadership roles in the NIH-funded Clinical Genome Resource Program and the International Global Alliance for Genomics and Health as well as committee roles in the American College of Medical Genetics and Genomics, she has been instrumental in developing standards and resources to support data sharing, genomic sequencing and the interpretation of genetic variation.

Jacquelyn Taylor headshot

Jacquelyn Taylor, PhD, RN

Jacquelyn is associate professor and Vernice D. Ferguson Chair in Health Equity at the Rory Meyers College of Nursing, New York University. Her work examines genomic and social factors contributing to health disparities for chronic conditions in underrepresented populations. In 2017, she was awarded the Presidential Early Career Award for Scientists and Engineers by President Obama.

Sharon F. Terry headshot

Sharon F. Terry, MA

Sharon is president and CEO of Genetic Alliance and co-founder of the Genetic Alliance Registry and Biobank. She is also the founding CEO of PXE International. She is co-PI of PCORnet’s Coordinating Center and the co-chair of the National Academy of Medicine Genomics and Health Roundtable. She led the coalition instrumental in passing the Genetic Information Nondiscrimination Act. She is a citizen scientist and advocate.

Matthew J. Thomas headshot

Matthew J. Thomas, ScM, CGC

Matthew is a pediatric and cardiovascular genetic counselor at University of Virginia Health System. From 2014 to 2017, he was chair of Virginia’s Advisory Board of Genetic Counselors. In 2013, he founded the first cardiovascular genetics program in the state.

Eliezer Van Allen headshot

Eliezer Van Allen, MD

Eliezer is an assistant professor of medicine at Harvard Medical School, a clinician at Dana-Farber/Partners Cancer Care and an associate member at the Broad Institute of MIT and Harvard. He is a computational biologist and medical oncologist whose research focuses on computational cancer genomics and applying new technologies to precision cancer medicine.

Catherine A. Wicklund headshot

Catherine A. Wicklund, MS, CGC

Catherine is a director of the Graduate Program in Genetic Counseling at Northwestern University and associate professor in the Department of Obstetrics and Gynecology. She is past president of the National Society of Genetic Counselors (NSGC) and NSGC’s representative on the National Academies of Sciences, Engineering, Medicine Roundtable on Genomics and Precision Health. Ms. Wicklund’s expertise is in genetic counseling and genomic education, and her research interests include bringing personalized medicine into broader clinical use.

UCSF logo
NYU logo
Northwestern Medicine logo
Harvard Medical School logo
The Ohio State University Comprehensive Cancer Center logo
Boston Children's Hospital logo
University of Virginia Health System logo
The University of Alabama logo
UCSF logo
NYU logo
Northwestern Medicine logo
Harvard Medical School logo
The Ohio State University Comprehensive Cancer Center logo
Boston Children's Hospital logo
The University of Alabama logo
University of Virginia Health System logo